Oxford Nanopore Technologies, which develops avant-garde technology to examine individual molecules, has increased its revenue to £134m in 2021, up from £114m in 2020. The company has also posted losses of £167m, amid a decline in Covid testing sales.
Oxford Nanopore Technology sees revenue spike in 2021 despite rise in losses
Share
